Sign in
4

Changes in Ownership

REGENERON PHARMACEUTICALS, INC. Filed Acc 0001104659-23-099992

Director acquired 240 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Schenkein David P · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2023-09-08 Grant or award : show line 1 in the form +240 240 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-09-08 Grant or award : show line 2 in the form Non-Qualified Stock Option (right to buy) +2,739 2,739 D
Loading xslF345X05/tm2325700-4_4seq1.xml…